Tag: Biosimilar
Unlocking the Lucrative $120 Billion Biosimilar Market
Between now and 2030, nearly 100 biologics in the US are expected to lose their exclusivity, resulting in a significant $120 billion in sales...
Tag: Biosimilar
Unlocking the Lucrative $120 Billion Biosimilar Market
Between now and 2030, nearly 100 biologics in the US are expected to lose their exclusivity, resulting in a significant $120 billion in sales...